多重抗藥性淋病的診斷治療與衍生的倫理問題

Diagnosis, Therapy, and Ethical Issues in the Treatment of Multidrug Resistant Neisseria Gonorrhoeae

10.7023/TJFM.201009.0145

黃信陽(Hsin-Yang Huang)；陳彥元(Yen-Yuan Chen)；江宜勳(Yi-Xun Jiang)；梁繼權(Kai-Kuen Leung)

gonorrhea ； quinolone resistance ； sexually transmitted disease ； expedited treatment ； medical ethics

台灣家庭醫學雜誌

20卷3期（2010 / 09 / 01）

145 - 151

繁體中文

淋病屬第三類法定傳染病，大部分皆在基層診所診斷治療。過去對penicillin類及quinolone抗藥性問題不斷浮現，在東亞地區quinolone抗藥性的比例達80%以上，2006年美國疾病管制局不建議使用fluoroquinolone治療淋病。在台灣ceftriaxone目前可有效根除泌尿生殖道淋病感染。本文報告二位ciprofloxacin抗藥性淋病尿道炎的年輕男性診斷與治療過程，也討論性伴侶的治療與衍生的倫理議題和法律爭議。

Gonorrhea, usually diagnosed and treated in primary care clinics, is classified as a third-category notifiable infectious diseases which requires mandatory reporting to the Taiwan Centers for Disease Control. In East Asia, as well as in Taiwan, up to 80% of gonorrheal cases are quinolone-resistant. Due to the increasing number of cases of penicillin-resistant or quinolone-resistant gonorrhea, the United States Centers for Disease Control and Prevention stopped suggesting treating gonorrhea with fluoroquinolone in 2006. In this paper, we report the cases of two young male adults with ciprofloxacin-resistant gonorrheal urethritis. One of them was initially treated with fluoroquinolone and was a treatment failure. Changing the antibiotic to ceftriaxone eventually resulted in treatment success. The other case was lost to follow-up after the diagnosis was confirmed and treatment with ceftriaxone was started. Although expedited treatment is a very important strategy for treating gonorrhea, physicians in primary care clinics in Taiwan still encounter dilemmas due to legal and ethical concerns when employing this strategy.

1. 衛生署疾病管制局：淋病。疾病介紹。Accessed on Oct 15, 2009, at: http://www.cdc.gov.tw.
2. 衛生署疾病管制局：臺灣地區第三類法定傳染病確定病例人數統計2008。Accessed on Oct 15, 2009, at: http://www.cdc.gov.tw/public/Attachment/95159515171.pdf
3. Akasaka, S.,Muratani, T.,Yamada, Y.(2001).Emergence of cephem-and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce ß-lactamase.J infect Chemother,7,49-50.
4. Barry, P.M.,Klausner(2009).The use of cephalosporins for gonorrhea: the impending problem of resistance.Expert Opin. Pharmacother,10,555-77.
5. Beauchamp, T.L.,Childress, J.F.(1994).Principles of Biomedical Ethics.New York:Oxford University Press.
6. Bignell, C.(2009).2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea.Int J STD AIDS,20,453-7.
7. Centers for Disease Control and Prevention(1989).Sexually transmitted diseases treatment guidelines.MMWR Morb Mortal Wkly Rep,38(suppl),1-43.
8. Centers for Disease Control and Prevention(2006).Sexually transmitted diseases treatment guidelines.MMWR Recomm Rep,55,1-94.
9. Chen, P.L.,Hsieh, Y.H.,Lee, H.C.(2009).Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.Int J STD AIDS,20,225-8.
10. Erbelding, E.J.,Zenilman, J.M.(2005).Toward better control of sexually transmitted diseases.N Engl J Med,352,720-1.
11. Glasier, A.,Gülmezoglu, A.M.,Schmid, G.P.,Moreno, C.G.,Look, P.F.V.(2006).Sexual and reproductive health: a matter of life and death.Lancet,368,1595-607.
12. Hooper, R.R.,Reynolds, G.H.,Jones, O.G.(1978).Cohort study of venereal disease I: the risk of gonorrhea transmission from infected women to men.Am J Epidemiol,108,136-44.
13. Hsueh, P.R.,Tseng, S.P.,Teng, L.J.,Ho, S.(2005).High prevalence of ciprofloxacin resistant Neisseria gonorrhoeae in Northern Taiwan.Clin Infect Dis,40,188-92.
14. Li, S.Y.,Wong, W.W.(2009).Antimicrobial resistance and molecular epidemiology of Neisseria gonorrhoeae in Taiwan.J Formos Med Assoc,108,681-2.
15. Lyss, S.B.,Kamb, M.L.,Peterman, T.A.(2003).Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States.Ann Intern Med,139,178-85.
16. Miller, K.E.(2006).Diagnosis and treatment of Neisseria gonorrhoeae infections.Am Fam Physician,73,1779-84.
17. Muratani, T.,Akasaka, S.,Kobayashi, T.(2001).Outbreak of Cefozopran (Penicillin, OralCephems, and Aztreonam)-Resistant Neisseria gonorrhoeae in Japan.Antimicrob Agents Chemother,45,3603-6.
18. Muratani, T.,Inatomi, H.,Ando, Y.,Kawai, S.,Akasaka, S.,Matsumoto, T.(2008).Single dose 1g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.Int J Urol,15,837-42.
19. Nelson, A.L.(2007).Gonorrheal Infections. Sexually Transmitted Diseases: A Practical Guide for Primary Care.New Jersey:Humana Press.
20. Newman, L.M.,Moran, J.S.,Worknowski, K.A.(2007).Update on the management of gonorrhea in adults in the United States.Clin Infect Dis,44,s84-101.
21. Peterman, T.A.,Tian, L.H.,Metcalf, C.A.(2006).High Incidence of New Sexually Transmitted Infections in the Year following a Sexually Transmitted Infection: A Case for Rescreening.Ann Intern Med,145,564-72.
22. Wang, S.A.,Harvey, A.B.,Conner, S.M.,Zaidi, A.A.,Knapp, J.S.,Whittington, W.L.H.(2007).Antimicrobial Resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: The Spread of Fluoroquinolone Resistance.Ann Intern Med,147,81-8.
23. Wong, W.W.,Huang, C.T.,Li, L.H.,Chiang, C.C.,Chen, B.D.,Li, S.Y.(2008).Molecular epidemiological identification of Neisseria gonorrhoeae Clonal Clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis.J Clin Microbiol,46,3931-4.
24. Workowski, K.A.,Berman, S.M.,Douglas, J.M., Jr(2008).Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent Need to Strengthen Prevention Strategies.Ann Intern Med,148,606-13.
25. World Health Organization(2008).Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western.Commun Dis Intell,32,48-51.
26. 李蘭蕙、張安隆、吳秀英、羅國華、莊苹(2004)。性傳染病之人口學特徵及病因。北市醫院雜誌，1，71-8。